Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| N2586 | Ruxolitinib | 0.3 | uM | 3 | MIP-1B | 66.0 | 61 | ||||
| N2586 | Tofacitinib | 0.3 | uM | 3 | MIP-1B | 63.0 | 81 | ||||
| N2586 | IKK16 | 2.0 | uM | 3 | MIP-1B | 63.0 | 75 | ||||
| N2586 | 3 | MIP-1B | 60.5 | 54 | |||||||
| RA2159 | Visfatin | 1 | ng/mL | 3 | MIP-1B | 64.5 | 74 | ||||
| RA2159 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 3 | MIP-1B | 60.5 | 56 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | MIP-1B | 63.5 | 62 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | MIP-1B | 60.0 | 59 | |
| RA2159 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | MIP-1B | 60.0 | 91 | |
| RA2159 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 3 | MIP-1B | 67.0 | 72 | |
| N2586 | Visfatin | 1 | ng/mL | 3 | MIP-1B | 61.0 | 57 | ||||
| N2586 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 3 | MIP-1B | 59.0 | 49 | |
| N2586 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | MIP-1B | 60.0 | 89 | |
| N2586 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | MIP-1B | 67.0 | 49 | |
| N2586 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | MIP-1B | 50.5 | 56 | |
| N2586 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 3 | MIP-1B | 63.0 | 62 | |
| RA2159 | Leptin | 1 | ng/mL | 3 | MIP-1B | 64.5 | 82 | ||||
| RA2159 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 3 | MIP-1B | 60.0 | 81 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | MIP-1B | 45.5 | 68 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | MIP-1B | 60.0 | 77 | |
| RA2159 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | MIP-1B | 58.0 | 81 | |
| RA2159 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 3 | MIP-1B | 60.0 | 83 | |
| N2586 | Leptin | 1 | ng/mL | 3 | MIP-1B | 61.5 | 90 | ||||
| N2586 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 3 | MIP-1B | 62.0 | 76 | |
| N2586 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | MIP-1B | 59.0 | 77 |